• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性多汗症患者人交感神经节中乙酰胆碱及其受体的表达。

Expression of acetylcholine and its receptor in human sympathetic ganglia in primary hyperhidrosis.

机构信息

Division of Thoracic Surgery, School of Medicine, University of Sao Paulo, Sao Paulo, Brazil.

出版信息

Ann Thorac Surg. 2013 Feb;95(2):465-70. doi: 10.1016/j.athoracsur.2012.10.068. Epub 2012 Dec 5.

DOI:10.1016/j.athoracsur.2012.10.068
PMID:23219256
Abstract

BACKGROUND

The pathophysiologic characteristics of primary hyperhidrosis are not well understood and seem to be related to a sympathetic nervous system dysfunction. The resection of thoracic sympathetic chain ganglia is the most effective treatment for hyperhidrosis; however sympathetic ganglia function in normal individuals and in patients with hyperhidrosis is unknown.

METHODS

A cross-sectional study, in which 2 groups of 20 subjects were analyzed: the hyperhidrosis group (HYP), comprised of patients with hyperhidrosis who were eligible for thoracic sympathectomy, and the control group (CON) comprised of brain-dead organ donors without a history of hyperhidrosis. For each subject, the following were performed: resection of the third left sympathetic ganglion, measurement of the ganglion's diameter, and immunohistochemical evaluation by quantification of strong and weak expression areas of primary antibodies against acetylcholine and alpha-7 neuronal nicotinic receptor subunit.

RESULTS

The presence of a strong alpha-7 subunit expression area was 4.85% in patients with primary hyperhidrosis and 2.34% in controls (p < 0.001), whereas the presence of a weak expression area was 11.48% in the HYP group and 4.59% in the CON group (p < 0.001). Strong acetylcholine expression was found in 4.95% of the total area in the HYP group and in 1.19% in the CON group (p < 0.001), whereas weak expression was found in 18.55% and 6.77% of the HYP and CON groups, respectively (p < 0.001). Furthermore, diameter of the ganglia was 0.71 cm in the HYP group and 0.53 cm in the CON group (p < 0.001).

CONCLUSIONS

There is a higher expression of acetylcholine and alpha-7 neuronal nicotinic receptor subunit in the sympathetic ganglia of patients with hyperhidrosis. Furthermore, the diameter of the thoracic sympathetic chain ganglia is larger in such patients.

摘要

背景

原发性多汗症的病理生理特征尚不清楚,似乎与交感神经系统功能障碍有关。胸交感神经链切除术是治疗多汗症最有效的方法;然而,正常人和多汗症患者的交感神经节功能尚不清楚。

方法

一项横断面研究,分析了 20 名患者的 2 组数据:多汗症组(HYP),由符合胸交感神经切除术条件的多汗症患者组成,对照组(CON)由无多汗症病史的脑死亡器官捐献者组成。对每位患者进行以下操作:切除第三左交感神经节,测量神经节直径,并通过定量分析针对乙酰胆碱和α-7 神经元烟碱受体亚单位的主要抗体的强和弱表达区域进行免疫组织化学评估。

结果

原发性多汗症患者的α-7 亚单位强表达区域为 4.85%,对照组为 2.34%(p < 0.001),而 HYP 组的弱表达区域为 11.48%,CON 组为 4.59%(p < 0.001)。HYP 组总区域中有 4.95%存在强乙酰胆碱表达,CON 组中有 1.19%(p < 0.001),而 HYP 组和 CON 组的弱表达分别为 18.55%和 6.77%(p < 0.001)。此外,HYP 组的神经节直径为 0.71cm,CON 组为 0.53cm(p < 0.001)。

结论

多汗症患者的交感神经节中乙酰胆碱和α-7 神经元烟碱受体亚单位表达较高。此外,此类患者的胸交感神经链神经节直径较大。

相似文献

1
Expression of acetylcholine and its receptor in human sympathetic ganglia in primary hyperhidrosis.原发性多汗症患者人交感神经节中乙酰胆碱及其受体的表达。
Ann Thorac Surg. 2013 Feb;95(2):465-70. doi: 10.1016/j.athoracsur.2012.10.068. Epub 2012 Dec 5.
2
Preservation of α-3 neuronal nicotinic acetylcholine receptor expression in sympathetic ganglia after brain death.脑死亡后,交感神经节中 α-3 神经元烟碱型乙酰胆碱受体表达的保存。
Mol Neurobiol. 2012 Apr;45(2):362-5. doi: 10.1007/s12035-012-8235-3. Epub 2012 Jan 25.
3
Morphometric analysis of thoracic ganglion neurons in subjects with and without primary palmar hyperhidrosis.原发性手掌多汗症患者与非患者胸神经节神经元的形态计量学分析
Ann Vasc Surg. 2014 May;28(4):1023-9. doi: 10.1016/j.avsg.2013.11.004. Epub 2013 Dec 14.
4
Invited commentary.特邀评论。
Ann Thorac Surg. 2013 Feb;95(2):470-1. doi: 10.1016/j.athoracsur.2012.11.003.
5
Hypermyelination and overexpression of neuregulin-1 in thoracic sympathetic nerves in patients with primary palmar hyperhidrosis.原发性手掌多汗症患者胸交感神经中超髓鞘化和神经调节蛋白-1 的过度表达。
J Clin Neurosci. 2012 Dec;19(12):1651-3. doi: 10.1016/j.jocn.2011.12.032. Epub 2012 Sep 19.
6
Endoscopic thoracic sympathectomy for palmar hyperhidrosis: efficacy of T2 and T3 ganglion resection.内镜下胸交感神经切除术治疗手掌多汗症:T2和T3神经节切除术的疗效
Surgery. 2005 Jul;138(1):40-5. doi: 10.1016/j.surg.2005.03.026.
7
Effects of endoscopic thoracic sympathectomy for primary hyperhidrosis on cardiac autonomic nervous activity.内镜下胸交感神经切除术治疗原发性多汗症对心脏自主神经活动的影响。
J Thorac Cardiovasc Surg. 2009 Mar;137(3):664-9. doi: 10.1016/j.jtcvs.2008.07.021. Epub 2008 Sep 24.
8
The Etiology of Primary Hyperhidrosis: A Systematic Review.原发性多汗症的病因:系统评价。
Clin Auton Res. 2017 Dec;27(6):379-383. doi: 10.1007/s10286-017-0456-0. Epub 2017 Aug 19.
9
Is T3 and T6 sympathetic clipping more effective in primary palmoplantar hyperhydrosis?T3和T6交感神经切断术在原发性掌跖多汗症中是否更有效?
Thorac Cardiovasc Surg. 2011 Sep;59(6):357-9. doi: 10.1055/s-0031-1280007. Epub 2011 Jul 15.
10
An assessment of plantar hyperhidrosis after endoscopic thoracic sympathicolysis.内镜下胸交感神经切断术后足底多汗症的评估。
Eur J Cardiothorac Surg. 2009 Aug;36(2):360-3. doi: 10.1016/j.ejcts.2009.02.062. Epub 2009 May 1.

引用本文的文献

1
PAI1 inhibits the pathogenesis of primary focal hyperhidrosis by targeting CHRNA1.PAI1 通过靶向 CHRNA1 抑制原发性局限性多汗症的发病机制。
Orphanet J Rare Dis. 2023 Jul 21;18(1):205. doi: 10.1186/s13023-023-02808-0.
2
Efficacy, Safety and Quality of Life of Oxybutynin versus Aluminum Chloride Hexahydrate in Treating Primary Palmar Hyperhidrosis.奥昔布宁与六水合氯化铝治疗原发性手掌多汗症的疗效、安全性及生活质量比较
Indian J Dermatol. 2022 May-Jun;67(3):222-227. doi: 10.4103/ijd.IJD_799_20.
3
Population-based analysis of the epidemiology of the surgical correction of hyperhidrosis in 1,216 patients over 11 years: a cross-sectional study.
基于人群的 11 年间 1216 例多汗症手术矫正流行病学分析:一项横断面研究。
Sao Paulo Med J. 2022 Nov-Dec;140(6):775-780. doi: 10.1590/1516-3180.2021.0773.R2.14022022.
4
Antagonist of Chrna1 prevents the pathogenesis of primary focal hyperhidrosis.Chrna1 拮抗剂可预防原发性局限性多汗症的发病机制。
Ann Clin Transl Neurol. 2022 Jun;9(6):786-794. doi: 10.1002/acn3.51558. Epub 2022 Apr 8.
5
Cohort study on 20 years' experience of bilateral video-assisted thoracic sympathectomy (VATS) for treatment of hyperhidrosis in 2431 patients.2431 例患者双侧电视辅助胸腔镜交感神经切断术(VATS)治疗多汗症 20 年经验的队列研究。
Sao Paulo Med J. 2022 Mar-Apr;140(2):284-289. doi: 10.1590/1516-3180.2021.0078.R1.23072021.
6
Current treatment options for craniofacial hyperhidrosis.颅面部多汗症的当前治疗选择。
J Vasc Bras. 2020 Nov 16;19:e20190152. doi: 10.1590/1677-5449.200152.
7
Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin.原发性多汗症患者的焦虑和抑郁症状及其与奥昔布宁临床治疗效果的关系。
Clinics (Sao Paulo). 2021 Jun 28;76:e2892. doi: 10.6061/clinics/2021/e2892. eCollection 2021.
8
Genome-wide linkage analysis of families with primary hyperhidrosis.原发性多汗症家族的全基因组连锁分析。
PLoS One. 2020 Dec 30;15(12):e0244565. doi: 10.1371/journal.pone.0244565. eCollection 2020.
9
Evaluation of Efficacy and Safety of Low Dose Glycopyrrolate in Management of Primary Hyperhidrosis---An Open Label Single Arm Study.低剂量格隆溴铵治疗原发性多汗症的疗效和安全性评估——一项开放标签单臂研究。
Indian Dermatol Online J. 2020 Nov 8;11(6):1012-1013. doi: 10.4103/idoj.IDOJ_179_20. eCollection 2020 Nov-Dec.
10
Genetic polymorphism analysis of patients with primary hyperhidrosis.原发性多汗症患者的基因多态性分析
Clin Cosmet Investig Dermatol. 2018 Oct 11;11:477-483. doi: 10.2147/CCID.S176842. eCollection 2018.